Qianyi Lu (Shusen Wang)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Patient Reported

Sentinel Lymph Node

Ejection Fraction

Top Venues

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kui-Kui Jiang, Danyang Zhou, Ruoxi Hong, Qianyi Lu, Fei Xu, Wen Xia, Qiufan Zheng, Shusen Wang
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors. Journal of personalized medicine 13 (2) (2023)
Kui-Kui Jiang, Danyang Zhou, Ruoxi Hong, Qianyi Lu, Fei Xu, Wen Xia, Qiufan Zheng, Shusen Wang
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors. Journal of personalized medicine 13 (2) (2023)
Kui-Kui Jiang, Danyang Zhou, Ruoxi Hong, Qianyi Lu, Fei Xu, Wen Xia, Qiufan Zheng, Shusen Wang
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors. Journal of personalized medicine 13 (2) (2023)
Kui-Kui Jiang, Danyang Zhou, Ruoxi Hong, Qianyi Lu, Fei Xu, Wen Xia, Qiufan Zheng, Shusen Wang
Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors. Journal of personalized medicine 13 (2) (2023)
Xin An, Fei Xu, Rongzhen Luo, Qiufan Zheng, Jiabin Lu, Yanhua Yang, Tao Qin, Zhongyu Yuan, Yanxia Shi, Wenqi Jiang, Qianyi Lu
The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer. BMC cancer 18 (1) (2018)